Geneva: The World Health Organisation (WHO) on Friday said it has suspended Gilead’s Remdesivir from its so-called prequalification list (an official list of medicines used as a benchmark for procurement by developing countries), after issuing guidance against its use in hospitalized COVID-19 patients, said media reports.
“Yes we have suspended it from the PQ (prequalification list),” Tarik Jasarevic said in an emailed response to Reuters, the reports added.
“The suspension is a signla to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for COVID.”
He added that the WHO was not aware that any international procurers were providing the drug to low-and middle-income countries, reports said.
Also Read: Govt Helpline Gives Emotional Support To Children Battling COVID
Bargarh: A new artist will be selected to play the mythological character King Kansa during…
Mumbai: Suhana Khan will be making her Bollywood debut with ‘King’ along with her superstar…
New Delhi: After Diljit Dosanjh called out the double standards of Telangana government for banning…
New Delhi: Recent actions and counter-actions in the Russia-Ukraine conflict have pushed the world to the…
Balangir: Three persons were arrested and fake IPS officers’ uniforms along with fake identity cards…
Mumbai: Abhishek Bachchan’s highly-anticipated film ‘I Want To Talk’ released in theatres on Friday, and the…
New Delhi: Accused of giving cash to secure votes ahead of election day in Maharashtra,…
Bhubaneswar: Chief Minister Mohan Charan Majhi attended the ‘Odisha State Day Celebrations’ at the 43rd…